These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 201573)

  • 1. Mechanism of the establishment of Epstein-Barr virus genome-containing lymphoid cell lines from infectious mononucleosis patients: studies with phosphonoacetate.
    Rickinson AB; Finerty S; Epstein MA
    Int J Cancer; 1977 Dec; 20(6):861-8. PubMed ID: 201573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by phosphonoacetate of the in vitro outgrowth of Epstein-Barr virus genome-containing cell lines from the blood of infectious mononucleosis patients.
    Rickinson AB; Finerty S; Epstein MA
    IARC Sci Publ (1971); 1978; (24 Pt 2):721-8. PubMed ID: 221394
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity of the transforming and replicative functions of Epstein--Barr virus to inhibition by phosphonoacetate.
    Rickinson AB; Epstein MA
    J Gen Virol; 1978 Aug; 40(2):409-20. PubMed ID: 211188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
    Lewin N; Aman P; Akerlund B; Gustavsson E; Carenfelt C; Lejdeborn L; Klein G; Klein E
    Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis.
    Rickinson AB; Jarvis JE; Crawford DH; Epstein MA
    Int J Cancer; 1974 Dec; 14(6):704-15. PubMed ID: 4377001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients.
    Rickinson AB; Crawford D; Epstein MA
    Clin Exp Immunol; 1977 Apr; 28(1):72-9. PubMed ID: 193663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on adult donor lymphocytes infected by EB virus in vivo or in vitro: origin of transformed cells arising in co-cultures with foetal lymphocytes.
    Rickinson AB; Finerty S; Epstein MA
    Int J Cancer; 1977 Jun; 19(6):775-82. PubMed ID: 194845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line.
    Rickinson AB; Moss DJ; Allen DJ; Wallace LE; Rowe M; Epstein MA
    Int J Cancer; 1981 May; 27(5):593-601. PubMed ID: 6169663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV.
    Margalith M; Manor D; Usieli V; Goldblum N
    Virology; 1980 Apr; 102(1):226-30. PubMed ID: 6245504
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis.
    Robinson J; Smith D; Niederman J
    Nature; 1980 Sep; 287(5780):334-5. PubMed ID: 6252472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
    Miller G; Lipman M
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):190-4. PubMed ID: 4346033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
    Szigeti R; Rabin H; Timar L; Klein G
    Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of circulating B lymphocytes infected with Epstein-Barr virus during infectious mononucleosis.
    Robinson JE
    Yale J Biol Med; 1982; 55(3-4):311-6. PubMed ID: 6295008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients.
    Rickinson AB; Moss DJ; Pope JH; Ahlberg N
    Int J Cancer; 1980 Jan; 25(1):59-65. PubMed ID: 6249763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
    Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
    Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr (EB) virus genome-containing, EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis.
    Crawford DH; Rickinson AB; Finerty S; Epstein MA
    J Gen Virol; 1978 Mar; 38(3):449-60. PubMed ID: 204732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of phosphonoacetic acid on early antigen synthesis in two Epstein-Barr virus producer cell lines.
    Patel P; Menezes J
    Virology; 1979 Jan; 92(1):236-9. PubMed ID: 217163
    [No Abstract]   [Full Text] [Related]  

  • 18. On the continuous culturing of B.95-8 cells in the presence of phosphonoacetic acid.
    Margalith M; Manor D; Goldblum N
    J Virol Methods; 1980; 1(6):349-54. PubMed ID: 6262340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-specific cytoskeletal early antigen in EBV-transformed cell lines.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    AIDS Res; 1986 Dec; 2 Suppl 1():S57-60. PubMed ID: 3030348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.